文献速递妇科产科

抗尿失禁手术对女性性功能的影响:SISTEr与TOMUS试验二次分析

Effect of Surgery for Stress Incontinence on Female Sexual Function.
PubMed 文献 · Obstet Gynecol · 2020-01-01

结果显示所有术式PISQ-12评分从基线至24个月均有临床重要改善,且术式间无显著差异;改善主要发生在术后12个月内并维持至24个月。

要点

  • 四种抗尿失禁手术后PISQ-12评分从基线至24个月均显著改善,术式间无差异。
  • 性功能改善主要发生在术后12个月内,并维持至24个月。
  • 客观和主观治愈率及合并手术与24个月PISQ-12评分独立相关。

核心结论

  • 抗尿失禁手术后女性性功能从基线至24个月整体改善,且不同术式间无显著差异。

研究设计与样本

  • 249例(26.9%)接受自体筋膜吊带,239例(25.9%)接受Burch阴道悬吊,216例(23.3%)接受耻骨后中段尿道吊带,220例(23.8%)接受经闭孔中段尿道吊带。
  • 使用PISQ-12短版问卷在基线、12个月和24个月评估性功能。

主要发现

  • 基线PISQ-12评分在四组分别为32.6、33.1、31.9、31.4,24个月分别为37.7、37.8、36.9、37.1,组内改善P<.01。
  • 12个月PISQ-12评分分别为37.7、37.8、36.9、37.1,与24个月比较P=.97。
  • 多变量分析显示客观和主观治愈率及合并手术与24个月PISQ-12评分独立相关。

关键数值与推荐

  • PISQ-12评分从基线至24个月改善具有临床重要性,且术式间无显著差异。
  • 12个月与24个月PISQ-12评分无显著差异(P=.97)。

临床怎么用

  • 术前咨询可告知患者抗尿失禁手术整体改善性功能,且术式选择对性功能影响无差异。
  • 性功能改善主要在术后第一年出现并维持,关注合并手术及治愈率对性功能的影响。

局限性

  • 本研究为二次分析,基线特征组间存在差异(种族、脱垂分期、合并手术、阴道分娩次数)。
  • 性功能评估采用PISQ-12问卷,可能未涵盖所有性功能维度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effects of four different surgical interventions for stress urinary incontinence (SUI) on 2-year postoperative sexual function. METHODS: This is a combined secondary analysis of SISTEr (Stress Incontinence Surgical Treatment Efficacy Trial) and TOMUS (Trial of Mid-Urethral Slings). Women in the original trials were randomized to receive surgical treatment for SUI with an autologous fascial sling or Burch colposuspension (SISTEr), or a retropubic or transobturator midurethral sling (TOMUS). Sexual function (assessed by the short version of the PISQ-12 [Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire]) was compared between groups at baseline, 12 and 24 months. Secondarily, the effects of subjective and objective surgical cure rates and the effect of concomitant surgical procedures on 24-month sexual function was explored. RESULTS: Nine hundred twenty-four women were included in this study: 249 (26.9%) had an autologous fascial sling, 239 (25.9%) underwent Burch colposuspension, 216 (23.3%) had a retropubic midurethral sling placed, and 220 (23.8%) had transobturator midurethral sling placed. Baseline characteristics (including PISQ-12 scores) were similar between the four treatment arms, with notable exceptions including race-ethnicity, prolapse stage, concomitant surgery, and number of vaginal deliveries. After adjustment for differences between the groups, there was a clinically important improvement in PISQ-12 scores over the 24-month postoperative period for all treatment groups, with no significant differences attributed to the type of anti-incontinence procedure (baseline PISQ-12: 32.6, 33.1, 31.9, 31.4; 24-month PISQ-12: 37.7, 37.8, 36.9, 37.1, P<.01). There was no significant difference in mean PISQ-12 scores between 12 months and 24 months (12-month PISQ-12: 37.7, 37.8, 36.9, 37.1; 24 months as above, P=.97). Multivariable analysis showed independent associations between objective and subjective cure rates as well as concomitant procedures with a 24-month PISQ-12 score. CONCLUSION: Women undergoing anti-incontinence surgery show overall improvement in sexual function from baseline to 24 months postoperatively, without significant differences based on surgical procedure performed. The majority of this improvement occurs in the first 12 months and is maintained over 24 months.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Glass Clark SM, Huang Q, Sima AP, et al. Effect of Surgery for Stress Incontinence on Female Sexual Function. Obstet Gynecol. 2020. PMID: 31923066. doi:10.1097/AOG.0000000000003648

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。